Today we present 19 new placebo and nocebo research papers, book chapters, comments and abstracts identified during November 2022. As usual, they are based on new PUBMED publication using the search terms „placebo“ and „nocebo“ and are hand-selected from more than 803 new publications during the preceding month. Previously published monthly updates can be found in our archive. Todays selection as well as all previously identified papers will also go into our placebo research library that currently contains nearly 5,000 relevant papers. If you would like to get access to the full database, please register for our newsletter and provide us with your email address and affiliation.
Annoni, M. (2022).
Using open notes to advance nocebo research: challenges and opportunities. J Med Ethics. doi:10.1136/jme-2022-108764
https://www.ncbi.nlm.nih.gov/pubmed/36424129
Belpomme, D., & Irigaray, P. (2022).
Why the psychogenic or psychosomatic theories for electrohypersensitivity causality should be abandoned, but not the hypothesis of a nocebo-associated symptom formation caused by electromagnetic fields conditioning in some patients. Environ Res, 114839. doi:10.1016/j.envres.2022.114839
https://www.ncbi.nlm.nih.gov/pubmed/36423669
Benedetti, F., Amanzio, M., Giovannelli, F., Craigs-Brackhahn, K., Arduino, C., & Shaibani, A. (2022).
Are Nocebo Effects in Adulthood Linked to Prenatal Maternal Cortisol Levels? Clin Neuropsychiatry, 19(5), 298-306. doi:10.36131/cnfioritieditore20220505
https://www.ncbi.nlm.nih.gov/pubmed/36340278
Clayton, A. (2022).
Gender-Affirming Treatment of Gender Dysphoria in Youth: A Perfect Storm Environment for the Placebo Effect-The Implications for Research and Clinical Practice. Arch Sex Behav. doi:10.1007/s10508-022-02472-8
https://www.ncbi.nlm.nih.gov/pubmed/36376741
Clemens, K. S., Faasse, K., Tan, W., Colagiuri, B., Colloca, L., Webster, R., Vase, L., Jason, E. & Geers, A. L. (2022).
Social communication pathways to COVID-19 vaccine side-effect expectations and experience. J Psychosom Res, 164, 111081. doi:10.1016/j.jpsychores.2022.111081
https://www.ncbi.nlm.nih.gov/pubmed/36399990
Faasse, K., Keevers, Y., de Groot, A., Nicholls, K., Helfer, S. G., & Geers, A. L. (2022).
Choice and the nocebo effect: If a little is good, more is better? J Psychosom Res, 164, 111083. doi:10.1016/j.jpsychores.2022.111083
https://www.ncbi.nlm.nih.gov/pubmed/36435093
Fiorio, M., Villa-Sanchez, B., Rossignati, F., & Emadi Andani, M. (2022).
The placebo effect shortens movement time in goal-directed movements. Sci Rep, 12(1), 19567. doi:10.1038/s41598-022-23489-y
https://www.ncbi.nlm.nih.gov/pubmed/36380087
Gaab, J. (2022).
The reasons for its effectiveness, however, remain in dispute-A tribute to Irving Kirsch. Front Psychol, 13, 1037678. doi:10.3389/fpsyg.2022.1037678
https://www.ncbi.nlm.nih.gov/pubmed/36452382
Gedin, F., Blome, S., Ponten, M., Lalouni, M., Fust, J., Raquette, A., Vadenmark Lundquist, V., Thompson, W. H. & Jensen, K. (2022).
Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis. JAMA Netw Open, 5(11), e2243848. doi:10.1001/jamanetworkopen.2022.43848
https://www.ncbi.nlm.nih.gov/pubmed/36441553
Hohenschurz-Schmidt, D., Thomson, O. P., Rossettini, G., Miciak, M., Newell, D., Roberts, L., Vase, L. & Draper-Rodi, J. (2022).
Avoiding nocebo and other undesirable effects in chiropractic, osteopathy and physiotherapy: An invitation to reflect. Musculoskelet Sci Pract, 62, 102677. doi:10.1016/j.msksp.2022.102677
https://www.ncbi.nlm.nih.gov/pubmed/36368170
Hu, T., Long, Y., Wei, L., Zheng, Y., Tong, Y., Yuan, M., Liu, C., Wang, X., Lin, Y., Guo, Q., Huang, J. & Du, L. (2022).
The underappreciated placebo effects and responses in randomized controlled trials on neck pain: a systematic review with meta-analysis. Arch Phys Med Rehabil. doi:10.1016/j.apmr.2022.10.013
https://www.ncbi.nlm.nih.gov/pubmed/36417969
Ito, A., Watanabe, Y., & Okumura, T. (2022).
Patients’ acceptance of placebo antibiotics in Japan: a prescription for antimicrobial resistance. J Pharm Policy Pract, 15(1), 79. doi:10.1186/s40545-022-00470-8
https://www.ncbi.nlm.nih.gov/pubmed/36348416
MacKrill, K. (2022).
Impact of media coverage on side effect reports from the COVID-19 vaccine. J Psychosom Res, 164, 111093. doi:10.1016/j.jpsychores.2022.111093
https://www.ncbi.nlm.nih.gov/pubmed/36435094
McMillan, B., & Davidge, G. (2022).
Nocebo effects: a price worth paying for full transparency? J Med Ethics. doi:10.1136/jme-2022-108766
https://www.ncbi.nlm.nih.gov/pubmed/36456171
Neumann, M., Wirtz, M. A., Lutz, G., Ernesti, A., & Edelhauser, F. (2022).
Why context matters when changing the diet: A narrative review of placebo, nocebo, and psychosocial context effects and implications for outcome research and nutrition counselling. Front Nutr, 9, 937065. doi:10.3389/fnut.2022.937065
https://www.ncbi.nlm.nih.gov/pubmed/36386910
Pan, Y., Frank, M. L., Kaptchuk, T. J., & Nestoriuc, Y. (2022).
“Let’s see what happens:”-Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial. PLoS One, 17(11), e0276499. doi:10.1371/journal.pone.0276499
https://www.ncbi.nlm.nih.gov/pubmed/36331921
Sayegh, R. (2022).
Hot flashes and the placebo effect: effective placebo or a research artifact? Menopause. doi:10.1097/GME.0000000000002122
https://www.ncbi.nlm.nih.gov/pubmed/36413712
Schaefer, M., Kuhnel, A., Schweitzer, F., Enge, S., & Gartner, M. (2022).
Neural underpinnings of open-label placebo effects in emotional distress. Neuropsychopharmacology. doi:10.1038/s41386-022-01501-3
https://www.ncbi.nlm.nih.gov/pubmed/36456814
Wong, E. C. L., Dulai, P. S., Marshall, J. K., Jairath, V., Reinisch, W., & Narula, N. (2022).
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn’s Disease. Inflamm Bowel Dis. doi:10.1093/ibd/izac231
https://www.ncbi.nlm.nih.gov/pubmed/36426810
Download PDF here.